Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma

Anne-Ségolène Cottereau , Sébastien Hapdey (1, 2) , Romain Modzelewski (2, 1) , Emmanuel Itti , Olivier Casasnovas , Hervé Tilly (3) , Pierre Vera (2, 1) , Michel A. Meignan , Stéphanie Becker (1, 2) , Isabelle Gardin (2, 1)

1 Service de médecine nucléaire [Rouen]
2 QuantIF-LITIS - Equipe Quantification en Imagerie Fonctionnelle
3 GPL - Groupe d'étude des proliférations lymphoïdes

The purpose of this study was to compare in a large series of peripheral T cell lymphoma, as a model of diffuse disease, the prognostic value of baseline total metabolic tumor volume (TMTV) measured on 18F-FDG PET/CT with adaptive thresholding methods with TMTV measured with a fixed 41% SUVmax threshold method.

Mots clés: PTCL; adaptive thresholds; lymphoma; metabolic tumor volume

Domaines: Cancer

Anne-Ségolène Cottereau, Sébastien Hapdey, Romain Modzelewski, Emmanuel Itti, Olivier Casasnovas, et al.. Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma. Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, 2016, San Diego, United States. pp.276 - 281, ⟨10.2967/jnumed.116.180406⟩. ⟨hal-01651896⟩